Navigation Links
CEL-SCI Corporation Releases Letter to Shareholders
Date:2/20/2009

ale following approval. We have also designed the facility to be used as a contract manufacturing facility during those times (e.g., during certain times in the Phase III study) when we will not be producing Multikine. This lucrative business could quickly become a multi-million dollar revenue generator for CEL-SCI.

  • We presented very promising data on a new rheumatoid arthritis vaccine discovered by CEL-SCI scientists. The data presented was as good as that achieved with Enbrel, a leading treatment for rheumatoid arthritis.

  • We started planning and pricing our global clinical trial designed to lead to marketing approval for Multikine. The recent strength of the dollar will reduce our Phase III study costs by several million dollars.

While we are pleased by these accomplishments, we also recognize that there are major challenges due to the severe financial downturn. This downturn has affected all of us, but we have taken immediate action. We very quickly reduced our expenditures and expanded our discussions with various pharmaceutical companies for a world-wide Multikine partnership. Things are very difficult all around for most companies, but we are seeing new strength in the bigger biotechnology names. This will hopefully trickle down to the smaller ones like us as well. The huge buyouts in the industry, Pfizer buying Wyeth and Roche trying to buy Genentech, will add over $100 billion in liquidity to the industry, and that too should help us down the road.

Let me share with you how we at CEL-SCI are dealing with and planning for recovery from this financial downturn. In our opinion, during such a difficult time as this you cannot rely on one strategy alone. Therefore we are pursuing the following multi-pronged strategy. To
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
2. CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect
3. CEL-SCI Expects to Take Delivery of New Manufacturing Facility on October 8, 2008
4. Data Suggest CEL-SCIs CEL-2000 Vaccine Prevents or Retards Permanent Damage of Rheumatoid Arthritis
5. CEL-SCI Corporation Reports First Quarter Financial Results
6. CEL-SCI Corporation Announces 2007 Financial Results
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
8. CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference
9. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
10. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
11. CEL-SCI CEO to Present Tomorrow at the Biotech / Pharma / Healthcare On-Line Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Aug. 22, 2014  Diplomat, the nation,s largest ... of two winners in the 2014 Innovations in ... LLC. The results of the competition were announced ... News. Diplomat was honored as ... & Training program. Through Diplomat University, the company ...
(Date:8/22/2014)... MC Medical, a subsidiary of Mitsubishi Corporation (MCM), ... OH medical device company, have formally agreed to ... visualization system in Japan . It is ... Japan in the latter half of 2015. ... product portfolio in endoscopic surgery market in Japan ...
(Date:8/22/2014)... , Aug. 22, 2014  Mark Riccio, ... (CT) imaging facility, is using the online crowd-funding ... even 5D imaging to researchers and would-be superheros ... asks "What would YOU do if you had ... to researchers and explorers everywhere, from elementary through ...
Breaking Medicine Technology:Diplomat honored as a Top Innovator by Specialty Pharmacy News 2MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Cornell's X-ray Imaging Lab Director Uses Kickstarter Campaign to "Democratize" Advanced 3D Imaging 2
(Date:8/22/2014)... August 22, 2014 AWeber, one ... that currently helps more than 120,000 small businesses ... the attention of Shane Michaels, prompting an investigative review. ... element for any online marketing campaign, despite what some ... the marketing world,” reports Michaels. “AWeber is a great ...
(Date:8/22/2014)... 2014 Buying a policy for different life ... unsure about available coverage types by insurers in the U.S. ... policy pricing to the public using its sortable tool at ... is free and is expected to promote the discounts and ... throughout the U.S. The system is designed to help an ...
(Date:8/22/2014)... The regional economy is about to get ... the grow again. The plant will invest $100 ... boost production of the popular Highlander midsize sport utility ... to $4 billion. This step allows Toyota to utilize ... to adjust its product mix to meet changing customer ...
(Date:8/22/2014)... York (PRWEB) August 22, 2014 ... morcellators ( http://www.injurybeacon.com/power-morcellator/ ) in uterine surgeries continues ... Massachusetts insurance companies have decided to limit coverage ... the Worcester Telegram, Blue Cross-Blue Shield of Massachusetts ... surgeries that involve morcellation as of September 1, ...
(Date:8/22/2014)... 11 (BIM) deletion in advanced non-small cell lung ... survival (PFS) in epidermal growth factor receptor (EGFR) ... patients. Also, BIM deletion independently predicts overall survival ... protein can activate the programmed cell death also ... deletion has been detected in 12.8% of the ...
Breaking Medicine News(10 mins):Health News:AWeber: Review Exposes Affordable Provider of Opt-In Email Marketing Services 2Health News:Principal Life Insurance Policies Now Quoted for Adults at Insurance Website Online 2Health News:Toyota Indiana Adding 300 Jobs to Build More Highlanders 2Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 2Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 3Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 4Health News:Deletion predicts survival in advanced non-small cell lung cancer 2
... organization will leverage Risk MonitorPro, (R) ... patient feedback and adverse events,CAMBRIDGE, MA, ... of healthcare quality and safety software, announced today that ... patient safety and quality of care initiatives. , Named ...
... poised to enter Animal Health Rapid Diagnostics Market with ... Jan. 13 Abaxis, Inc. (Nasdaq: ABAX ... instruments for both the medical and veterinary markets, announced ... Scientific for the manufacturing of a Canine Heartworm Lateral ...
... Association (NEA) awarded its Seal of Acceptance to ... NEA Seal of Acceptance is part of the association,s ... to improve the quality of life for people who ... our criteria for having no irritating ingredients and being ...
... Insurance Reports Job Opportunities for Commissioned Insurance Sales Agents Across the ... ... 2009 -- Despite recent reports by the U.S. Bureau of Labor ... continue throughout 2009, Combined Insurance, a leading provider of supplemental ...
... device can be used in home, rather than hospital, and can ... ... (PRWEB) January 13, 2009 -- MedFaxx has announced ... combines the most used form of electrotherapy in the world clinically ...
... on its recent analysis of the autoimmune disease ... with the 2008 European Frost & Sullivan Excellence ... incorporation of synthetically modified peptides for the validation ... autoimmune diseases and is also looking to adopt ...
Cached Medicine News:Health News:Woman's Hospital Selects rL Solutions for Improved Adverse Event and Patient Safety Reporting 2Health News:ABAXIS Announces Contract Manufacturing Agreement with SA Scientific, Ltd. 2Health News:ABAXIS Announces Contract Manufacturing Agreement with SA Scientific, Ltd. 3Health News:National Eczema Association Anoints Theraplex Products with Seal of Acceptance 2Health News:Leading Insurer Reports Positive Outlook for U.S. Insurance Industry Jobs in 2009 2Health News:Leading Insurer Reports Positive Outlook for U.S. Insurance Industry Jobs in 2009 3Health News:North Carolina Company Announces First Chronic Pain Control Unit Combining Two Most Used Forms of Electrotherapy For Chronic Pain - Tens & Interferential 2Health News:North Carolina Company Announces First Chronic Pain Control Unit Combining Two Most Used Forms of Electrotherapy For Chronic Pain - Tens & Interferential 3Health News:Frost & Sullivan Lauds Toscana Biomarkers' Outstanding Contributions to the R&D of Novel Biomarkers for the Diagnosis of Autoimmune Diseases 2Health News:Frost & Sullivan Lauds Toscana Biomarkers' Outstanding Contributions to the R&D of Novel Biomarkers for the Diagnosis of Autoimmune Diseases 3Health News:Frost & Sullivan Lauds Toscana Biomarkers' Outstanding Contributions to the R&D of Novel Biomarkers for the Diagnosis of Autoimmune Diseases 4
ArcticTemp Upright Freezer -20C. Thick wall insulation keeps your samples colder. Reversible door with magnetic gaskets. 2 shelves and a wire basket. Heavy duty compressor with 5 year warranty....
Undercounter Freezer -25C. White. Front opening freezer. 4 cubic ft capacity. Reversible door. Three slide-out drawers. Extra thick CFC insulation. Front lock. Front indicator lights. Attractive tabl...
... F 250 is a portable system for ... temperature measurements. Temperature compensated pH results can ... probe (ATC) or a 3-in-1 electrode. • ... calibration with Auto-Find automatic buffer recognition for ...
... a highly accurate portable, waterproof system for pH, ... compensated pH results can be obtained when used ... electrode. • This GLP/GMP compliant system includes an ... a computer. Up to 100 data sets can ...
Medicine Products: